Cadden is accused of having caused the deaths of dozens of people, for which he faces second-degree murder charges. Cadden used to be the co-owner and chief pharmacist at the New England Compounding Center, until around 2012, when he and his colleagues were implicated in a deadly meningitis outbreak that sickened hundreds of people in 20 states.
Melissa Healy with the Los Angeles Times reports that common anti-anxiety drugs may be linked to the development of Alzheimer's disease ("Drugs used for anxiety, sleep are linked to Alzheimer's disease in older people"). According to new research, Healy writes, "Older people who have relied on a class of drugs called benzodiazepines to reduce anxiety or induce sleep are at higher risk [...]."
In an indication of how much compounding pharmacies have taken advantage of the absence of regulatory oversight, a government inspection of a facility this week led to yet another product recall.
It has been months since public health authorities registered another fatality related to the tragic fungal meningitis outbreak traced to a contaminated compounding pharmacy last fall. Two people died in the last month alone, bringing the total national fatality count to 51.
The fungal meningitis outbreak has taken the nation by surprise and it shows no signs of slowing. As of this week, contaminated steroid treatments have sickened nearly 250 people and 19 of those cases were fatal. These numbers will become outdated quickly as states report more cases every day.
Defective drugs are a huge issue throughout the country. Many people develop serious illnesses and injuries because of defective pharmaceuticals and medication errors.
A recent whistleblower lawsuit alleges that drugmaker Takeda Pharmaceutical Co. hid some of the adverse effects of its diabetes-drug Actos from federal regulators. The whistleblower alleges that the company was aware of a link between its dangerous prescription drug and hundreds of congested heart failure cases but opted not to report these events in the U.S. Food and Drug Administration's Adverse Event Reporting System.
A study into prescription errors indicates that medication errors are shockingly common and often lead to the wrongful death of patients. One study of Canadian hospitals found that one in 13 patients suffered from a medical malpractice and that a quarter of these medical errors were drug-related.
A Louisiana judge has set a preliminary court date for the pending lawsuits against drug giant Takeda Pharmaceuticals. The defective drug lawsuits are in regards to Takeda's number one diabetes drug, Actos, which is believed to carry an increased risk of bladder cancer.